Industry News
Scale-up problems force layoffs at Ambri
Listed biotech Ambri Ltd has laid off 15 staff in response to unexpected manufacturing problems in scaling up its biosensor technology for commercial production. [ + ]
Computer program reveals optimum microstructure
A Princeton chemist has developed a general mathematical system for designing materials that perform two functions at once, even when the desired properties sometimes conflict with each other.
[ + ]World-first Australian truffle find
An Australian scientist has made a discovery which is electrifying world fungal biology - a new truffle genus related to the famous Amanita family, or fairy toadstools.
[ + ]International grants for water research
A senior UNSW researcher is part of an international science collaboration, funded jointly by the European Union and the Australian Government under the Innovation Access (International Science and Technology) program, to study drinking water risk management.
[ + ]Happy holidays from all of us
Australian Biotechnology News will be closed for the holidays, until January 6, 2003. [ + ]
Research points the whey forward for milk
Milk is the first food that any mammal tastes, a fluid perfectly formulated by nature for the nutritional and developmental needs of newborn mammals. [ + ]
Biotech's six million dollar woman
A young biotech that is developing technology to improve racehorse performance is easily outpacing the field when it comes to attracting development funding. [ + ]
Bioprospect signs deal with US company Diversa
Listed company BioProspect has signed a pact with a second major drug developer interested in testing its library of compounds extracted from Australian plants. [ + ]
CSIRO maths guru quits for private sector
CSIRO is losing the services of one of the country's premier biostatisticians, Dr Mervyn Thomas, who is leaving to launch his own consultancy in the private sector. [ + ]
Meditech considers large-scale m'facture after discoveries
Researchers, funded by Meditech, at Curtin University of Technology in Perth have identified carbohydrate compounds that specifically bind to proteins involved in asthma, atopic dermatitis and other inflammatory responses. [ + ]
ESI gets rights to diabetes technology
Singapore-based stem cell company ES Cell International (ESI) has acquired patent rights to technology relating to the transformation of stem cells into insulin-producing cells from US company Curis. [ + ]
Local biotechs unhappy with ASIC report
A number of listed biotechs named by the Australian Securities and Investments Commission (ASIC) as facing potential solvency problems are crying foul. [ + ]
Natural complexity structures to work in big business
A group which explores the living world for fresh ideas about how to design and manage organisations has been launched.
[ + ]US maize shipments tipped to to raise anti-GM hackles
As a desperate measure to keep alive elite dairy and beef cattle herds suffering in one of the worst droughts of the past century, Australia's livestock industries are moving to ship in maize from the US. [ + ]
Genetraks raises $6m
Genetraks, a start-up biotech developing blood tests for use in pre-race evaluation of animals such as racehorses, has received a $6 million injection of venture capital. [ + ]